Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

164497

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Stem Cells
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what proportion of the mitochondrial diseases listed in Annex D of the Mitochondrial Donation consultation document, February 2014, include degenerative neurological conditions; whether the Human Fertilisation and Embryology Authority (HFEA) has received any suggestions from either research licence holders or nominal licensees that stem cells derived by somatic cell nuclear transfer "are likely to carry very low levels of mtDNA mutation and are therefore likely to be suitable for therapeutic use" to "treat degenerative disease caused by mtDNA mutations" as described in Scientific Reports (DOI: 10.1038/srep03844); and what assessment they have made of the feasibility of treating neurological conditions associated with mitochondrial disease in this way in light of findings recently reported in the journal Cell Stem Cell (DOI: 10.1016/j.stem.2014.11.003) and the Proceedings of the National Academy of Sciences of the United States of America (Volume 111, no. 26, pages 9633–38).
tabling member printed	Lord Alton of Liverpool
uin	HL3090
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>We are advised that all conditions listed in Annex D of the mitochondrial donation consultation document ultimately lead to progressive degenerative neurological conditions.</p><p> </p><p> </p><p> </p><p>The Human Fertilisation and Embryology Authority (HFEA) has advised that one of the research projects it licenses is investigating the use of embryonic stem cells “to improve the outcome of infertility treatments, and to make progress towards the wider application of IVF-based techniques to help prevent and treat degenerative disease”. The latest interim inspection report relating to this project can be found on the HFEA’s website at:</p><p> </p><p> </p><p> </p><p><a href="http://guide.hfea.gov.uk/guide/InspectionReport.aspx?code=17&amp;s=l&amp;&amp;nav=3" target="_blank">http://guide.hfea.gov.uk/guide/InspectionReport.aspx?code=17&amp;s=l&amp;&amp;nav=3</a></p><p> </p><p> </p><p> </p><p>The HFEA has also advised that it has not made the assessment stated by the noble Lord in respect of the two journal articles.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 15:58:39 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

164499

registered interest
date	24/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Negligence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government by how much the provision for clinical negligence claims against the National Health Service has grown in the last year; why it has grown; and what strategy is in place for reducing that amount.
tabling member printed	Lord Sharkey
uin	HL3092
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>As at 31 March 2014, the National Health Service Litigation Authority (NHS LA) estimates that it has potential liabilities of £26.1 billion, of which £25.7 billion relates to clinical negligence. This is an increase of £3.1 billion from 31 March 201<del class="ministerial">4<ins class="ministerial">3</ins></del>, which can mainly be attributed to a continual rise in clinical negligence claims over recent years. There are a number of factors driving this increase, including the rise in the number of patients cared for and in the complexity of their care; and the general rise in litigation across a number of sectors including the NHS, driven in part by ‘no win, no fee’ agreements. It is anticipated that the effect of the latter is likely to diminish as a result of the Government’s Legal Aid Sentencing and Punishment of Offenders Act of 2012.</p><p> </p><p>The Department believes the best way to reduce negligence claims is to improve patient care and safety. In March 2014, the Secretary of State for Health issued a call to action to make the NHS the safest healthcare system in the world and achieve a three-year goal to halve avoidable harm and save 6,000 lives. The Sign up to Safety campaign embodies the ambition of the NHS to build a culture of safety, bringing together individuals and organisations with a contribution to make towards the patient safety goal. Elements of this campaign will focus on a reduction in avoidable harm that can lead to compensation claims. Organisations that sign up are setting out what they will do to strengthen patient safety, including a safety improvement plan which shows how their organisation intends to save lives and reduce harm for patients over the next three years. The NHS Litigation Authority, which already provides a “safety and learning service” to trusts<strong>,</strong> will support those organisations which have patient safety improvement plans that show a likely reduction in their higher volume, higher value claims.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 16:04:05 question first ministerially corrected 13/01/2015 14:37:59 answering member 2000 label Biography information for Earl Howe previous answer version 31769 answering member printed Earl Howe answering member 2000 label Biography information for Earl Howe
tabling member	4196 label Biography information for Lord Sharkey

164217

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Quality Commission
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their current assessment of whether there is duplication of activities by the Care Quality Commission and local authorities.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3047
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.</p><p> </p><p> </p><p> </p><p>CQC has outlined its commitment to working with local authorities to minimise duplication, including in adult social care, in its provider handbooks which were published on 9 October 2014. This includes CQC inspection managers having regular meetings with their assigned local authorities, attending local safeguarding meetings where relevant and also local safeguarding boards to provide an update on CQC’s work annually. In addition, providers are asked to complete a CQC Provider Information Return and an evaluation form before an inspection. 79% of residential care providers responding said they had not recently been asked to provide similar information for any other purposes.</p><p> </p><p>CQC has organised its adult social care directorate to reflect local authority boundaries which will allow the alignment of CQC staff with local authorities for commissioning and information sharing and safeguarding.</p><p> </p><p>CQC’s Adult Social Care inspection staff also have relationships with local clinical commissioning groups (CCGs) which enables the CCGs to update CQC on the outcomes of their contract monitoring visits as well as CQC providing the CCG with information and outcomes of recent inspections in the area.</p><p> </p><p>CQC anticipates that as its new methodology beds down and more services are rated, local authorities will have greater confidence in the regulatory system for adult social care and therefore reduce their activity for those services with ‘good’ and ‘outstanding’ ratings. Local authorities will always have their own contract monitoring duties to fulfil but one of the benefits of the new regulatory approach should be a minimisation of unnecessary duplication of activities. There is work underway between CQC and the Association of Directors of Adult Social Services to develop an information sharing portal.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3048 question first answered 03/12/2014 15:58:49 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164218

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their current assessment of the level of co-ordination between the Care Quality Commission and commissioners for places in care homes.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3048
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.</p><p> </p><p> </p><p> </p><p>CQC has outlined its commitment to working with local authorities to minimise duplication, including in adult social care, in its provider handbooks which were published on 9 October 2014. This includes CQC inspection managers having regular meetings with their assigned local authorities, attending local safeguarding meetings where relevant and also local safeguarding boards to provide an update on CQC’s work annually. In addition, providers are asked to complete a CQC Provider Information Return and an evaluation form before an inspection. 79% of residential care providers responding said they had not recently been asked to provide similar information for any other purposes.</p><p> </p><p>CQC has organised its adult social care directorate to reflect local authority boundaries which will allow the alignment of CQC staff with local authorities for commissioning and information sharing and safeguarding.</p><p> </p><p>CQC’s Adult Social Care inspection staff also have relationships with local clinical commissioning groups (CCGs) which enables the CCGs to update CQC on the outcomes of their contract monitoring visits as well as CQC providing the CCG with information and outcomes of recent inspections in the area.</p><p> </p><p>CQC anticipates that as its new methodology beds down and more services are rated, local authorities will have greater confidence in the regulatory system for adult social care and therefore reduce their activity for those services with ‘good’ and ‘outstanding’ ratings. Local authorities will always have their own contract monitoring duties to fulfil but one of the benefits of the new regulatory approach should be a minimisation of unnecessary duplication of activities. There is work underway between CQC and the Association of Directors of Adult Social Services to develop an information sharing portal.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3047 question first answered 03/12/2014 15:58:49 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164219

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they consider that there is sufficient distinction in the Care Quality Commission's handling of major and minor non-compliance issues when publicly naming non-compliant care homes; and if not, on what basis they made that assessment.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3049
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.</p><p> </p><p> </p><p> </p><p>The provider handbooks that set out the end-to-end process, CQC’s Key Lines of Enquiry and the assessment framework were published on the 9 October 2014. CQC’s new approach contains ratings that provide a much finer grading of quality with services being rated outstanding, good, requires improvement or inadequate. CQC inspection reports clearly set out whether regulations have been breached or not, and the action that a provider must take to return to meeting its legal requirements.</p><p> </p> answering member printed Earl Howe question first answered 03/12/2014 15:52:46 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164220

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Quality Commission
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment has been made by the Care Quality Commission of proposals in the Deregulation Bill to create a statutory duty for the Commission to consider economic growth when carrying out their functions.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3050
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Care Quality Commission (CQC) inspects health and adult social care services in order to ensure they provide people with safe, compassionate, high quality care. The effect of the Deregulation Bill is that regulators, including the CQC, will have regard to economic growth and ensure regulatory action is necessary and proportionate. CQC, as an arms-length body of the Department, is able to brief Parliamentarians on how it carries out its functions, including the new duty to have regard to economic growth.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3051 HL3052 question first answered 03/12/2014 15:54:20 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164221

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Quality Commission
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will instruct the Care Quality Commission to brief parliamentarians on the impact of proposals in the Deregulation Bill to create a statutory duty for the Commission to consider economic growth when carrying out their functions.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3051
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Care Quality Commission (CQC) inspects health and adult social care services in order to ensure they provide people with safe, compassionate, high quality care. The effect of the Deregulation Bill is that regulators, including the CQC, will have regard to economic growth and ensure regulatory action is necessary and proportionate. CQC, as an arms-length body of the Department, is able to brief Parliamentarians on how it carries out its functions, including the new duty to have regard to economic growth.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3050 HL3052 question first answered 03/12/2014 15:54:20 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164222

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Quality Commission
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how they will ensure that proposals in the Deregulation Bill to create a statutory duty on the Care Quality Commission to consider economic growth when carrying out its functions will not impact on the protection of the public.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3052
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Care Quality Commission (CQC) inspects health and adult social care services in order to ensure they provide people with safe, compassionate, high quality care. The effect of the Deregulation Bill is that regulators, including the CQC, will have regard to economic growth and ensure regulatory action is necessary and proportionate. CQC, as an arms-length body of the Department, is able to brief Parliamentarians on how it carries out its functions, including the new duty to have regard to economic growth.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3050 HL3051 question first answered 03/12/2014 15:54:20 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164224

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Rare Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what discussions they have had with NHS England about improving the process involved in assessing medicines used for treating rare diseases as described in the recent Genetics Alliance UK Patient Charter <i>Patients and Priorities of NHS England's commissioning of medicines for rare diseases</i>.
tabling member printed	Lord Turnberg
uin	HL3054
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>NHS England has advised that it is considering the recommendations in the Patient Charter which was published by Genetic Alliance UK on 21 October 2014.</p><p> </p><p> </p><p> </p><p>NHS England is working with stakeholders to review the process through which it develops commissioning policies. NHS England is also considering whether it may be appropriate to reduce the usual 12-week consultation period where a technology affects a very small number of patients who have been actively engaged in developing a commissioning policy and whose views have been taken into account during that development.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 12:16:24 answering member 2000 label Biography information for Earl Howe
tabling member	2537 label Biography information for Lord Turnberg

164227

registered interest
date	21/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	West Africa: Ebola
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what discussions they have had with the government of the Republic of Ireland on measures to deal with those passengers entering either that country or the United Kingdom from areas where ebola is at present widespread.
tabling member printed	Lord Eames
uin	HL3057
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>Jane Ellison, Parliamentary under Secretary of State for Public Health, had a discussion with Leo Varadkar, the Irish Health Minister, on 30 October where they discussed a number of issues around Ebola. In addition, Dr John Watson, Deputy Chief Medical Officer, had a general discussion on Ebola with his Irish counterparts on 11 November.</p><p> </p><p> </p><p> </p><p>In addition, there are ongoing discussions at European Union level between officials in which both the Republic of Ireland and United Kingdom representatives participate.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3058 question first answered 04/12/2014 16:01:11 answering member 2000 label Biography information for Earl Howe
tabling member	2793 label Biography information for Lord Eames